Abstract

OVERVIEW OF PHARMACEUTICAL SALES AND MARKETING REPORT ON ITRACONAZOLE

Shrisha R. Kemble, Adinath V. Javanjal*, Chetan C. Sherikar, Rushikesh V. Raut, Dr. Nilesh Chougule

.

Abstract

Ringworm, athlete's foot, and fungal nail infections are among the most prevalent fungal illnesses, and they are driving this market throughout the projection period. In addition, the prevalence of illnesses like candidiasis and mucormycosis is rising and others that are anticipated to speed up growth. Additionally, antifungal medications prevent fungal infections from occurring by limiting the growth of fungal germs on the host cell.[1] Thus, the availability of a variety of antifungal medications for the treatment of fungal infections and over-the-counter medications for the treatment of dermatological infections is favourably affecting the growth of the antifungal medication market. According to a 2019 article from the National Center for Biotechnology Information, 625,000 people die from cryptococcosis worldwide every year, with an estimated 1 million cases being documented. As a result, the market is seeing a rise in demand for these medications due to the rising prevalence of cryptococcosis.

Keywords: Pharmaceutical sales and marketing, Pharmaceutical promotion, Pharmaceutical industry, Marketing strategies, Antifungal, Itraconazole.